Viewpoints » Visby Medical to Exhibit at the ACOG Annual Clinical and Scientific Meeting

04/02/2022Viewpoint

Visby Medical to Exhibit at the ACOG Annual Clinical and Scientific Meeting

Visby Medical will be exhibiting at the ACOG Annual Clinical and Scientific Meeting (ACSM). ACSM has long been a gathering of the leading women’s health care experts.

Visby Medical to Exhibit at the ACOG Annual Clinical and Scientific Meeting

ACOG Annual Clinical and Scientific Meeting

May 6-8, 2022

San Diego Convention Center
111 W Harbor Dr, San Diego, CA 92101

Founded in 1951, ACOG is the premier professional membership organization for obstetrician–gynecologists. The College produces practice guidelines for health care professionals and educational materials for patients, provides practice management and career support, facilitates programs and initiatives to improve women’s health, and advocates for members and patients. The Annual Clinical and Scientific Meeting (ACSM) has long been a gathering of the leading women’s health care experts. ACSM provides attendees with cutting-edge research, clinical best practices, and collaborative solutions to the challenges faced by their members. Sessions for the meeting will center around four tracks: obstetrics, gynecology, professional development, and office practice. Concise and focused sessions across a variety of topics promise to engage attendees while providing opportunities to connect. The programming for ACSM 2022 will emphasize this year’s theme: Reconnect, Recharge, Reset.

Visby Medical - ACOG Annual Clinical and Scientific Meeting

Don’t miss our presentation at the Product Theater and stop by our booth #905 to hold our revolutionary palm-sized PCR for three critical sexual health targets — chlamydia, gonorrhea, and trichomonas.

Register

Learn more about the Visby Medical Sexual Health Test

Read more articles & insights

02/21/2024Press Release

CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million to develop a portable polymerase chain reaction (PCR) test that can detect gonorrhea and assess its susceptibility to ciprofloxacin.

Read More
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test

12/01/2023Viewpoint

Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

As the chill in the air intensifies, healthcare systems worldwide brace themselves for a seasonal upswing in respiratory illnesses. This year, the situation is exacerbated by the continuing threat of COVID-19 alongside the potential resurgence of seasonal influenza (Flu A and Flu B).

Read More
Bracing for Winter Surges: The Imperative of PCR Point-of-Care Testing in Urgent Cares

11/18/2023Viewpoint

A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

In the setting of a global pandemic, the specter of SARS-CoV-2 infection has understandably dominated the differential diagnosis for respiratory symptoms. However, it is crucial to remember that other respiratory pathogens continue to circulate, potentially leading to varied clinical presentations in patients who share the same exposure or living environment.

Read More
A Case Study on the Importance of Testing: When SARS-CoV-2 Meets Influenza A

05/11/2023Viewpoint

Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected

As we move into the post-public health emergency landscape with the expiration of the national emergency concerning the coronavirus disease 2019 (COVID-19) pandemic on May 11, 2023, it is essential to understand how the healthcare industry has adapted and evolved to address the unique challenges posed by the COVID-19 pandemic.

Read More
Navigating the Post-Public Health Emergency Landscape: How the Visby Medical Respiratory Health Test EUA Remains Unaffected